Jaqueline Jeruss, M.D., Ph.D., Director, University of Michigan Breast Care Center, discusses a study that looked at younger patients with the diagnosis of breast cancer who have been identified as an at-risk population for poor initiation and continuation of Tamoxifen.
Related Presenters
Dr. Jeruss is an Associate Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. ...
